C-reactive protein (CRP) levels in babies with gastroschisis managed with preformed silos

Ashok Daya Ram1, Melanie Drewett, David Burge

  • 1Department of Paediatric Surgery, Birmingham Children's Hospital, Birmingham, United Kingdom. ashokdram@hotmail.com

Insights

Serum C-reactive protein (CRP) levels are expected to rise in infants with gastroschisis treated with a preformed silo. This elevation occurs even without infection and can help avoid unnecessary antibiotic use.

Area of Science:

  • Pediatric Surgery
  • Neonatology
  • Inflammatory Markers

Background:

  • Gastroschisis is a congenital abdominal wall defect.
  • Management often involves silo placement for staged closure.
  • Elevated inflammatory markers can complicate clinical assessment.

Purpose of the Study:

  • To evaluate C-reactive protein (CRP) levels in infants with gastroschisis.
  • To assess CRP changes during preformed silo management and nonoperative closure.
  • To establish a baseline for expected CRP elevation in this cohort.

Main Methods:

  • Prospective collection of CRP measurements in infants with gastroschisis.
  • Inclusion criteria: preformed silo placement and nonoperative closure.
  • Exclusion criteria: operative closure, surgical silo, or confirmed sepsis.

Main Results:

  • Data analyzed for 43 infants.
  • Median CRP at birth was 8 mg/L (range 6-55).
  • Median CRP at closure significantly increased to 42 mg/L (range 35-68).

Conclusions:

  • Elevated serum CRP is a normal finding in infants with gastroschisis managed via preformed silo.
  • This expected elevation occurs in the absence of infection.
  • Understanding these CRP levels can prevent unnecessary antibiotic administration.
Abstract

Related Concept Videos